BioPharma Credit PLC

BPCP.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents£5,620£86,202£120,527£94,709
Short-Term Investments£0£48,851£0£0
Receivables£31,797£20,226£19,727£9,594
Inventory£0£0-£111£0
Other Curr. Assets£0£91£222£416
Total Curr. Assets£37,417£155,370£140,365£104,719
Property Plant & Equip (Net)£0£0£0£0
Goodwill£0£0£0£0
Intangibles£0£0£0£0
Long-Term Investments£1,162,200£1,201,362£1,223,651£1,265,898
Tax Assets£0£0£0£0
Other NC Assets£0£0£0£0
Total NC Assets£1,162,200£1,201,362£1,223,651£1,265,898
Other Assets£0£0£0£0
Total Assets£1,199,617£1,356,732£1,364,016£1,370,617
Liabilities
Payables£946£0£0£2,222
Short-Term Debt£0£0£0£0
Tax Payable£0£0£0£0
Deferred Revenue£0£0£0£0
Other Curr. Liab.£16,938£15,871£26,301£4,120
Total Curr. Liab.£17,884£15,871£26,301£6,342
LT Debt£0£0£0£0
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£55£0£262£558
Total NC Liab.£55£0£262£558
Other Liabilities£0£0£0£0
Cap. Leases£0£0£0£0
Total Liabilities£17,939£15,871£26,563£6,900
Equity
Pref Stock£0£0£0£0
Common Stock£13,739£13,739£13,739£13,739
Retained Earnings£560,814£719,997£716,589£742,853
AOCI£0£0£0£0
Other Equity£607,125£607,125£607,125£607,125
Total Equity£1,181,678£1,340,861£1,337,453£1,363,717
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£1,199,617£1,356,732£1,364,016£1,370,617
Net Debt-£5,620-£86,202-£120,527-£94,709